KDM3B shows tumor-suppressive activity and transcriptionally regulates HOXA1 through retinoic acid response elements in acute myeloid leukemia

References

• Wang P, Lin C, Smith ER, et al. Global analysis of H3K4 methylation defines MLL family member targets and points to a role for MLL1-mediated H3K4 methylation in the regulation of transcriptional initiation by RNA polymerase II. Mol Cell Biol. 2009;29:6074–6085.
   PubMed Web of Science ®Google Scholar
• Neff T, Sinha AU, Kluk MJ, et al. Polycomb repressive complex 2 is required for MLL-AF9 leukemia. Proc Nat Acad Sci USA. 2012;109:5028–5033.
   PubMed Web of Science ®Google Scholar
• Zhu L, Li Q, Wong SH, et al. ASH1L links histone H3 lysine 36 di-methylation to MLL leukemia. Cancer Discov. 2016;6:770–783.
   PubMed Web of Science ®Google Scholar
• Chang MJ, Wu H, Achille NJ, et al. Histone H3 lysine 79 methyltransferase Dot1 is required for immortalization by MLL oncogenes. Cancer Res. 2010;70:10234–10242.
   PubMed Web of Science ®Google Scholar
• Chen X, Skutt-Kakaria K, Davison J, et al. G9a/GLP-dependent histone H3K9me2 patterning during human hematopoietic stem cell lineage commitment. Genes Dev. 2012;26:2499–2511.
   PubMed Web of Science ®Google Scholar
• Muller-Tidow C, Klein HU, Hascher A, et al. Profiling of histone H3 lysine 9 trimethylation levels predicts transcription factor activity and survival in acute myeloid leukemia. Blood. 2010;116:3564–3571.
   PubMed Web of Science ®Google Scholar
• Cloos PA, Christensen J, Agger K, et al. Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease. Genes Dev. 2008;22:1115–1140.
   PubMed Web of Science ®Google Scholar
• Hu Z, Gomes I, Horrigan SK, et al. A novel nuclear protein, 5qNCA (LOC51780) is a candidate for the myeloid leukemia tumor suppressor gene on chromosome 5 band q31. Oncogene. 2001;20:6946–6954.
   PubMed Web of Science ®Google Scholar
• Kim JY, Kim KB, Eom GH, et al. KDM3B is the H3K9 demethylase involved in transcriptional activation of lmo2 in leukemia. Mol Cell Biol. 2012;32:2917–2933.
   PubMed Web of Science ®Google Scholar
• Chen M, Zhu N, Liu X, et al. JMJD1C is required for the survival of acute myeloid leukemia by functioning as a coactivator for key transcription factors. Genes Dev. 2015;29:2123–2139.
   PubMed Web of Science ®Google Scholar
• Sroczynska P, Cruickshank VA, Bukowski J, et al. shRNA screening identifies JMJD1C as being required for leukemia maintenance. Blood. 2014;123:1870–1882.
   PubMed Web of Science ®Google Scholar
• Zhu N, Chen M, Eng R, et al. MLL-AF9- and HOXA9-mediated acute myeloid leukemia stem cell self-renewal requires JMJD1C. J Clin Invest. 2016;126:997–1011.
   PubMed Web of Science ®Google Scholar
• Argiropoulos B, Humphries RK. Hox genes in hematopoiesis and leukemogenesis. Oncogene. 2007;26:6766–6776.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhu T, Chen Y, et al. Human growth hormone-regulated HOXA1 is a human mammary epithelial oncogene. J Biol Chem. 2003;278:7580–7590.
   PubMed Web of Science ®Google Scholar
• Bitu CC, Destro MF, Carrera M, et al. HOXA1 is overexpressed in oral squamous cell carcinomas and its expression is correlated with poor prognosis. BMC Cancer. 2012;12:146.
   PubMed Web of Science ®Google Scholar
• Wardwell-Ozgo J, Dogruluk T, Gifford A, et al. HOXA1 drives melanoma tumor growth and metastasis and elicits an invasion gene expression signature that prognosticates clinical outcome. Oncogene. 2014;33:1017–1026.
   PubMed Web of Science ®Google Scholar
• Zha TZ, Hu BS, Yu HF, et al. Overexpression of HOXA1 correlates with poor prognosis in patients with hepatocellular carcinoma. Tumor Biol. 2012;33:2125–2134.
   PubMed Web of Science ®Google Scholar
• Zhan M, Qu Q, Wang G, et al. Let-7c inhibits NSCLC cell proliferation by targeting HOXA1. Asian Pac J Cancer Prev. 2013;14:387–392.
   PubMedGoogle Scholar
• Bach C, Buhl S, Mueller D, et al. Leukemogenic transformation by HOXA cluster genes. Blood. 2010;115:2910–2918.
   PubMed Web of Science ®Google Scholar
• Cho HS, Toyokawa G, Daigo Y, et al. The JmjC domain-containing histone demethylase KDM3A is a positive regulator of the G1/S transition in cancer cells via transcriptional regulation of the HOXA1 gene. Int J Cancer. 2012;131:E179–E189.
   PubMed Web of Science ®Google Scholar
• Mahajan K, Lawrence HR, Lawrence NJ, et al. ACK1 tyrosine kinase interacts with histone demethylase KDM3A to regulate the mammary tumor oncogene HOXA1. J Biol Chem. 2014;289:28179–28191.
   PubMed Web of Science ®Google Scholar
• Gautier L, Cope L, Bolstad BM, et al. affy – analysis of Affymetrix GeneChip data at the probe level. Bioinformatics. 2004;20:307–315.
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Nat Acad Sci USA. 2005;102:15545–15550.
   PubMed Web of Science ®Google Scholar
• DupeDavenne V, Brocard M, Dolle J, et al. In vivo functional analysis of the Hoxa-1 3' retinoic acid response element (3'RARE). Development. 1997;124:399–410.
   PubMed Web of Science ®Google Scholar
• Kolm PJ, Sive HL. Regulation of the Xenopus labial homeodomain genes, HoxA1 and HoxD1: activation by retinoids and peptide growth factors. Dev Biol. 1995;167:34–49.
   PubMed Web of Science ®Google Scholar
• Felix CA, Lange BJ, Hosler MR, et al. Chromosome band 11q23 translocation breakpoints are DNA topoisomerase II cleavage sites. Cancer Res. 1995;55:4287–4292.
   PubMed Web of Science ®Google Scholar
• Le Beau MM, Espinosa 3rd R, Neuman WL, et al. Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases. Proc Nat Acad Sci USA. 1993;90:5484–5488.
   PubMed Web of Science ®Google Scholar
• MacKinnon RN, Kannourakis G, Wall M, et al. A cryptic deletion in 5q31.2 provides further evidence for a minimally deleted region in myelodysplastic syndromes. Cancer Genet. 2011;204:187–194.
   PubMed Web of Science ®Google Scholar
• Graubert TA, Payton MA, Shao J, et al. Integrated genomic analysis implicates haploinsufficiency of multiple chromosome 5q31.2 genes in de novo myelodysplastic syndromes pathogenesis. PloS One. 2009;4:e4583.
   PubMed Web of Science ®Google Scholar
• Yamane K, Tateishi K, Klose RJ, et al. PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation. Mol Cell. 2007;25:801–812.
   PubMed Web of Science ®Google Scholar
• Wong SH, Goode DL, Iwasaki M, et al. The H3K4-methyl epigenome regulates leukemia stem cell oncogenic potential. Cancer Cell. 2015;28:198–209.
   PubMed Web of Science ®Google Scholar
• Skvarova Kramarzova K, Fiser K, Mejstrikova E, et al. Homeobox gene expression in acute myeloid leukemia is linked to typical underlying molecular aberrations. J Hematol Oncol. 2014;7:94.
   PubMed Web of Science ®Google Scholar
• Nakayama J, Rice JC, Strahl BD, et al. Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly. Science. 2001;292:110–113.
   PubMed Web of Science ®Google Scholar
• Tamaru H, Zhang X, McMillen D, et al. Trimethylated lysine 9 of histone H3 is a mark for DNA methylation in Neurospora crassa. Nat Genet. 2003;34:75–79.
   PubMed Web of Science ®Google Scholar
• Wen B, Wu H, Shinkai Y, et al. Large histone H3 lysine 9 dimethylated chromatin blocks distinguish differentiated from embryonic stem cells. Nat Genet. 2009;41:246–250.
   PubMed Web of Science ®Google Scholar
• Vakoc CR, Mandat SA, Olenchock BA, et al. Histone H3 lysine 9 methylation and HP1gamma are associated with transcription elongation through mammalian chromatin. Mol Cell. 2005;19:381–391.
   PubMed Web of Science ®Google Scholar
• Wiencke JK, Zheng S, Morrison Z, et al. Differentially expressed genes are marked by histone 3 lysine 9 trimethylation in human cancer cells. Oncogene. 2008;27:2412–2421.
   PubMed Web of Science ®Google Scholar
• Cui K, Zang C, Roh TY, et al. Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation. Cell Stem Cell. 2009;4:80–93.
   PubMed Web of Science ®Google Scholar
• Gupta J, Kumar S, Li J, et al. Histone H3 lysine 4 monomethylation (H3K4me1) and H3 lysine 9 monomethylation (H3K9me1): distribution and their association in regulating gene expression under hyperglycaemic/hyperinsulinemic conditions in 3T3 cells. Biochimie. 2012;94:2656–2664.
   PubMed Web of Science ®Google Scholar